European Journal of Medicinal Chemistry (2020)
Update date:2022-08-15
Topics:
Camara, Ramatoulie
Ogbeni, Deborah
Gerstmann, Lisa
Ostovar, Mehrnoosh
Hurer, Ellie
Scott, Mark
Mahmoud, Nasir G.
Radon, Tomasz
Crnogorac-Jurcevic, Tatjana
Patel, Pryank
Mackenzie, Louise S.
Chau, David Y.S.
Kirton, Stewart B.
Rossiter, Sharon
S100P, a calcium-binding protein, is known to advance tumor progression and metastasis in pancreatic and several other cancers. Herein is described the in silico identification of a putative binding pocket of S100P to identify, synthesize and evaluate novel small molecules with the potential to selectively bind S100P and inhibit its activation of cell survival and metastatic pathways. The virtual screening of a drug-like database against the S100P model led to the identification of over 100 clusters of diverse scaffolds. A representative test set identified a number of structurally unrelated hits that inhibit S100P-RAGE interaction, measured by ELISA, and reduce in vitro cell invasion selectively in S100P-expressing pancreatic cancer cells at 10 μM. This study establishes a proof of concept in the potential for rational design of small molecule S100P inhibitors for drug candidate development.
View MoreNanjing Legend Pharmaceutical & Chemical Co., Ltd.
Contact:+86-25-83767696
Address:14-7 Zhongshan Lu Guluo District, Nanjing
Rugao Jinling Chemical Co., Ltd.
Contact:0086-513-68005586
Address:Lianluo new village huangshi town Rugao city Jiangsu Province.
Contact:+86-27-85733560
Address:NO.308,QINGNIAN RD.,WUHAN,CHINA
Hubei Danao Pharmaceutical Co.,Ltd.
website:http://www.danaopharm.com
Contact:+86-719-5251167
Address:Fandan Road,Danjiangkou,Hubei
Suzhou HeChuang Chemical Co.,Ltd.
Contact:+86-512-88800520
Address:No.9 Guanchao Rd,Changshu Advanced Materials Industy Park
Doi:10.1016/j.molcata.2014.12.006
(2015)Doi:10.1039/c5ra17951c
(2015)Doi:10.1016/S0040-4039(01)81594-X
(1984)Doi:10.1021/ja953160x
(1996)Doi:10.1055/s-0028-1083379
(2008)Doi:10.1080/24701556.2020.1799394
(2021)